ArticleEndocrine connections2025
Coffee intake and the vasopressin system: an epidemiological and experimental study.
Article in Endocrine connections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Coffee is epidemiologically linked to health benefits and risks. Coffee is thought to be a diuretic. However, it can still contribute to daily fluid intake. Vasopressin is the most important physiological regulator of body fluid balance and diuresis. This study aimed to map the effects of coffee intake on vasopressin concentration. In the population-based cross-sectional Malmö Offspring Study (n = 3,270, age 18-75 years, 47% males) we performed linear regression analyses to investigate the association between coffee intake and plasma concentration of copeptin (a vasopressin surrogate marker). Coffee intake was assessed using a 4-day food record. Moreover, we compared plasma copeptin concentrations after intake of 4 dL of coffee and 10 mL of water (control) in an experimental study (n = 26, age 35-70 years, 15% males). Results showed that higher coffee intake was associated with lower copeptin concentration after adjusting for co-variables, including total fluid intake. In the coffee experiment, the acute intake of 4 dL of coffee significantly decreased copeptin concentration at all time points (every 30 min for 4 h) compared with baseline concentration. A 27% maximum reduction on average was observed within 150 min. Intake of 10 mL of water also resulted in a slight reduction of copeptin concentration within 2 h. These findings suggest that copeptin concentration is lower among individuals with high coffee intake and can be acutely decreased by coffee intake. The mechanisms behind the coffee-induced reduction in copeptin concentration may involve oral and gut reflexes, volume load, and/or specific effects of coffee compounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.